quinoxalines has been researched along with Autoimmune Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bähr, M; Boretius, S; Diem, R; Fairless, R; Frahm, J; Gadjanski, I; Hochmeister, S; Knöferle, J; Lingor, P; Michaelis, T; Sättler, MB; Storch, MK; Sühs, KW; Williams, SK | 1 |
He, CM; Hu, XH; Jin, K; Song, LF; Wang, ZL; Wu, XH | 1 |
Ohashi, PS; Woodgett, JR | 1 |
Björklund, U; Holmdahl, R; Hultqvist, M; Nandakumar, KS | 1 |
4 other study(ies) available for quinoxalines and Autoimmune Diseases
Article | Year |
---|---|
Role of n-type voltage-dependent calcium channels in autoimmune optic neuritis.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Amlodipine; Amyloid beta-Protein Precursor; Animals; Autoimmune Diseases; Calcium; Calcium Channel Blockers; Calcium Channels, N-Type; Cytokines; Disease Models, Animal; Drug Interactions; Ectodysplasins; Egtazic Acid; Excitatory Amino Acid Antagonists; Female; Glial Fibrillary Acidic Protein; Magnetic Resonance Imaging; Manganese; Myelin Proteins; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Neoplasm Proteins; omega-Conotoxin GVIA; Optic Nerve; Optic Neuritis; Quinoxalines; Rats; RNA-Binding Proteins | 2009 |
[Intervention effect of PI3Kgamma inhibitor AS605240 on autoimmune myocarditis in mice].
Topics: Animals; Autoimmune Diseases; Chemokine CCL2; Class Ib Phosphatidylinositol 3-Kinase; Down-Regulation; Isoenzymes; Male; Mice; Mice, Inbred BALB C; Myocarditis; Phosphoinositide-3 Kinase Inhibitors; Quinoxalines; Random Allocation; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2009 |
Modulating autoimmunity: pick your PI3 kinase.
Topics: Animals; Arthritis; Autoimmune Diseases; Cell Line; Enzyme Activation; Enzyme Inhibitors; Isoenzymes; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Quinoxalines; Thiazolidinediones | 2005 |
The novel small molecule drug Rabeximod is effective in reducing disease severity of mouse models of autoimmune disorders.
Topics: Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Collagen; Cytokines; Disease Models, Animal; Immunosuppressive Agents; Indoles; Mice; Mice, Mutant Strains; Multiple Sclerosis; Quinoxalines; Rats; Reactive Oxygen Species; Treatment Outcome | 2009 |